High-risk features at baseline: Prior symptomatic gallstones or biliary colic Existing asymptomatic stones on prior imaging Obesity (BMI 35), particularly in female patients over 40 Rapid prior weight loss history Crohn's disease or terminal ileal resection (impairs bile salt reabsorption) Family history of cholelithiasis Patients with prior symptomatic gallstones should discuss prophylactic cholecystectomy with a surgeon before starting semaglutide, or at minimum have a baseline ultrasound documented in the chart
Additionally, based on titles and abstracts, the retrieved studies were manually screened according to the inclusion and exclusion criteria
the observed reduction may result from partial thiol oxidation, or conformational effects limiting solvent accessibility and restricting DTNB interaction
Inhalation of the nanoparticles led to greater and faster cardiac accumulation than I.V
According to FDA prescribing information, nausea rates vary by indication and dosageapproximately 15-20% of patients taking semaglutide for diabetes management experience nausea, while rates increase to up to 44% for those on higher doses for weight management
Clinics can now offer doctor-supervised, science-backed therapies that deliver measurable outcomes